Identifying and managing lupus nephritis during pregnancy

References

• Friedman EA, Rutherford JW. Pregnancy and lupus erythematosus. Obstet Gynecol. 1956;8:601–610.
   PubMed Web of Science ®Google Scholar
• Boyd A Jr, Stoddard FJ, Pierce DF. Lupus erythematosus simulating toxemia of pregnancy. Am J Obstet Gynecol. 1957;74:1062–1065.
   PubMed Web of Science ®Google Scholar
• Cox JB. Disseminated lupus erythematosus in pregnancy. Obstet Gynecol. 1965;26:511–514.
   PubMed Web of Science ®Google Scholar
• Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008;358:929–939.
   PubMed Web of Science ®Google Scholar
• Carvalheiras G, Vita P, Marta S, et al. Pregnancy and systemic lupus erythematosus: review of clinical features and outcome of 51 pregnancies at a single institution. Clin Rev Allergy Immunol. 2010;38:302–306.
   PubMed Web of Science ®Google Scholar
• Carmona F, Font J, Cervera R, et al. Obstetrical outcome of pregnancy in patients with systemic Lupus Erythematosus. A study of 60 cases. Eur J Obstet Gynecol Reprod Biol. 1999;83:137–142.
   PubMed Web of Science ®Google Scholar
• Tower C, Crocker I, Chirico D, et al. SLE and pregnancy: the potential role for regulatory T cells. Nat Rev Rheumatol. 2011;7:124–128.
   PubMed Web of Science ®Google Scholar
• Zen M, Ghirardello A, Iaccarino L, et al. Hormones, immune response, and pregnancy in healthy women and SLE patients. Swiss Med Wkly. 2010;140:187–201.
   PubMed Web of Science ®Google Scholar
• Doria A, Ghirardello A, Iaccarino L, et al. Pregnancy, cytokines, and disease activity in systemic lupus erythematosus. Arthritis Rheum. 2004;51:989–995.
   PubMed Web of Science ®Google Scholar
• Iaccarino L, Ghirardello A, Zen M, et al. Polarization of TH2 response is decreased during pregnancy in systemic lupus erythematosus. Reumatismo. 2012;64:314–320.
   PubMedGoogle Scholar
• Ortega LM, Schultz DR, Lenz O, et al. Review: lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions. Lupus. 2010;19:557–574.
   PubMed Web of Science ®Google Scholar
• Hardy CJ, Palmer BP, Morton SJ, et al. Pregnancy outcome and family size in systemic lupus erythematosus: a case-control study. Rheumatology. 1999;38(6):559–563.
   PubMed Web of Science ®Google Scholar
• Hickman RA, Gordon C. Causes and management of infertility in systemic lupus erythematosus. Rheumatology (Oxford). 2011;50:1551–1558.
   PubMed Web of Science ®Google Scholar
• Packham DK, Lam SS, Nicholls K, et al. Lupus nephritis and pregnancy. Q J Med. 1992;83:315.24.
   PubMedGoogle Scholar
• Silva CA, Bonfa E, Ostensen M. Maintenance of fertility in patients with rheumatic diseases needing antiinflammatory and immunosuppressive drugs. Arthritis Care Res. 2010;62:1682–1690.
   PubMed Web of Science ®Google Scholar
• Borella E, Lojacono A, Gatto M, et al. Predictors of maternal and fetal complications in SLE patients: a prospective study. Immunol Res. 2014;60:170–176.
   PubMed Web of Science ®Google Scholar
• Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.
   PubMed Web of Science ®Google Scholar
• Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–2686.
   PubMed Web of Science ®Google Scholar
• Moroni G, Quaglini S, Gallelli B, et al. The long-term outcome of 93 patients with proliferative lupus nephritis. Nephrol Dial Transplant. 2007;22:2531–2539.
   PubMed Web of Science ®Google Scholar
• Buyon JP. Updates on lupus and pregnancy. Bull NYU Hosp Jt Dis. 2009;67(3):271–275.
   PubMedGoogle Scholar
• Conradand KP, Davison JM. The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin? Am J Physiol Renal Physiol. 2014;306(10):F1121–F1135.
   Google Scholar
• Doria A, Tincani A, Lockshin MD. Challenges of lupus pregnancies. Rheumatology. 2008;47 Suppl 3:iii9–12.
   PubMedGoogle Scholar
• Cabiddu G, Castellino S, Gernone G, et al. A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy. J Nephrol. 2016;29(3):277–303.
   PubMed Web of Science ®Google Scholar
• Bili E, Tsolakidis D, Stangou S, et al. Pregnancy management and outcome in women with chronic kidney disease. Hippokratia. 2013;17(2):163–168.
   PubMed Web of Science ®Google Scholar
• Cabiddu G, Castellino S, Gernone G, et al. Kidney and pregnancy study group of Italian Society of Nephrology. Best practices on pregnancy on dialysis: the Italian Study Group on Kidney and Pregnancy. J Nephol. 2015;28(3):279–288.
   PubMed Web of Science ®Google Scholar
• Sivasuthan G, Dahwa R, John GT, et al. Dialysis and pregnancy in end stage kidney disease associated with lupus nephritis. Case Rep Med. 2013;2013:923581.
   PubMedGoogle Scholar
• Smyth A, Oliveira GH, Lahr BD, et al. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010;5:2060–2068.
   PubMed Web of Science ®Google Scholar
• Tandon A, Ibanez D, Gladman DD, et al. The effect of pregnancy on lupus nephritis. Arthritis Rheum. 2004;50:3941–3946.
   PubMed Web of Science ®Google Scholar
• Bramham K, Hunt BJ, Bewley S, et al. Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis. J Rheumatol. 2011;38:1906–1913.
   PubMed Web of Science ®Google Scholar
• Huong DL, Wechsler B, Vauthier-Brouzes D, et al. Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre. Ann Rheum Dis. 2001;60:599–604.
   PubMed Web of Science ®Google Scholar
• Wagner SJ, Craici I, Reed D, et al. Maternal and foetal outcomes in pregnant patients with active lupus nephritis. Lupus. 2009;18:342–347.
   PubMed Web of Science ®Google Scholar
• Salmon JE, Heuser C, Triebwasser M, et al. Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. PLoS Med. 2011;8:e1001013.
   PubMed Web of Science ®Google Scholar
• Repke JT. Hypertensive disorders of pregnancy. Differentiating pre-eclampsia from active SLE. J Reprod Med. 1998;43:35.
   Web of Science ®Google Scholar
• Buyon JP, Cronstein BN, Morris M, et al. Serum complement values (C3 & C4) to differentiate between systemic lupus activity and pre-eclampsia. Am J Med. 1986;81:194–200.
   PubMed Web of Science ®Google Scholar
• Stanhope TJ, White WM, Moder KG, et al. Obstetric nephrology: lupus and lupus nephritis in pregnancy. Clin J Am Soc Nephrol. 2012;7(12):2089–2099.
   PubMed Web of Science ®Google Scholar
• Le Thi Huong D, Wechsler B, Vauthier-Brouzes D, et al. The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome. Rheumatology. 2006;45(3):332–338.
   PubMed Web of Science ®Google Scholar
• Qazi U, Lam C, Karumanchi SA, et al. Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus. J Rheumatol. 2008;35(4):631–634.
   PubMed Web of Science ®Google Scholar
• Kuc S, Wortelboer EJ, van Rijn BB, et al. Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv. 2011;66(4):225–239.
   PubMed Web of Science ®Google Scholar
• Vinet E, Clarke AE, Gordon C, et al. Decreased live births in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2011;63(7):1068–1072.
   PubMed Web of Science ®Google Scholar
• Clowse ME, Witter FR, Magder LC, et al. The impact of increased lupus activity on obstetrical outcomes. Arthritis Rheum. 2005;52(2):514–522.
   PubMed Web of Science ®Google Scholar
• Yan Yuen S, Krizova A, Ouimet JM, et al. Pregnancy outcome in systemic lupus erythematosus (SLE) is improving: results from a case control study and literature review. Open Rheumatol J. 2008;2:89–98.
   PubMedGoogle Scholar
• Imbasciati E, Tincani A, Gregorini G, et al. Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant. 2009;24(2):519–525.
   PubMed Web of Science ®Google Scholar
• Cortes-Hernandez J, Ordi-Ros J, Paredes F, et al. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford). 2002;41:643–650.
   PubMed Web of Science ®Google Scholar
• Moroni G, Quaglini S, Banfi G, et al. Pregnancy in lupus nephritis. Am J Kidney Dis. 2002;40:713–720.
   PubMed Web of Science ®Google Scholar
• Hayslett JP, Lynn RI. Effect of pregnancy in patients with lupus nephropathy. Kidney Int. 1980;18:207–220.
   PubMed Web of Science ®Google Scholar
• Mintz G, Niz J, Gutierrez G, et al. Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J Rheumatol. 1986;13:732–739.
   PubMed Web of Science ®Google Scholar
• Rahman FZ, Rahman J, Al-Suleiman SA, et al. Pregnancy outcome in lupus nephropathy. Arch Gynecol Obstet. 2005;271:222–226.
   PubMedGoogle Scholar
• Urowitz MB, Gladman DD, Farewell VT, et al. Lupus and pregnancy studies. Arthritis Rheum. 1993;36:1392–1397.
   PubMed Web of Science ®Google Scholar
• Clark CA, Spitzer KA, Nadler JN, et al. Preterm deliveries in women with systemic lupus erythematosus. J Rheumatol. 2003;30(10):2127–2132.
   PubMed Web of Science ®Google Scholar
• Clowse MEB, Magder LS, Petri M. The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus. J Rheumatol. 2011;38:1012–1016.
   PubMed Web of Science ®Google Scholar
• Stagnaro-Green A, Akhter E, Yim C, et al. Thyroid disease in pregnant women with systemic lupus erythematosus: increased preterm delivery. Lupus. 2011;20:690–699.
   PubMed Web of Science ®Google Scholar
• Clowse MEB, Magder LS, Witter F, et al. Early risk factors for pregnancy loss in lupus. Obstet Gynecol. 2006;107(2 Pt 1):293–299.
   PubMed Web of Science ®Google Scholar
• Ritchie J, Smyth A, Tower C, et al. Maternal deaths in women with lupus nephritis: a review of published evidence. Lupus. 2012;21(5):534–541.
   PubMed Web of Science ®Google Scholar
• Zhao C, Zhao J, Huang Y, et al. New-onset systemic lupus erythematosus during pregnancy. Clin Rheumatol. 2013;32:815–822.
   PubMed Web of Science ®Google Scholar
• Packham DK, Lam SS, Nicholls K, et al. Lupus nephritis and pregnancy. Q J Med. 1992;83:315–324.
   PubMedGoogle Scholar
• Ponticelli C, Moroni G. Renal transplantation in lupus nephritis. Lupus. 2005;14:95–98.
   PubMed Web of Science ®Google Scholar
• Wyld ML, Clayton PA, Jesudason S, et al. Pregnancy outcomes for kidney transplant recipients. Am J Transplant. 2013;13(12):3173–3182.
   PubMed Web of Science ®Google Scholar
• McGrory CH, McCloskey LJ, DeHoratius RJ, et al. Pregnancy outcomes in female renal recipients: a comparison of systemic lupus erythematosus with other diagnoses. Am J Transplant. 2003;3:35–42.
   PubMed Web of Science ®Google Scholar
• Campise M, Giglio E, Trespidi L, et al. Pregnancies in women receiving renal transplant for lupus nephritis: description of nine pregnancies and review of the literature. Lupus. 2015;24(11):1210–1213.
   PubMed Web of Science ®Google Scholar
• Cimaz R, Spence DL, Hornberger L, et al. Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies. J Pediatr. 2003;142:678–683.
   PubMed Web of Science ®Google Scholar
• Hornberger LK, Al Rajaa N. Spectrum of cardiac involvement in neonatal lupus. Scand J Immunol. 2010;72:189–197.
   PubMed Web of Science ®Google Scholar
• Villain E, Coastedoat-Chalumeau N, Marijon E, et al. Presentation and prognosis of complete atrioventricular block in childhood, according to maternal antibody status. J Am Coll Cardiol. 2006;48:1682–1687.
   PubMed Web of Science ®Google Scholar
• Costedoat-Chalumeau N, Amoura Z, Villain E, et al. Anti- SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options. Arthritis Res Ther. 2005;7:69–73.
   PubMed Web of Science ®Google Scholar
• Brucato A, Cimaz R, Caporali R, et al. Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies. Clin Rev Allergy Immunol. 2011;40:27–41.
   PubMed Web of Science ®Google Scholar
• Gladman G, Silverman ED, Yuk-Law, et al. Fetal echocardiographic screening of pregnancies of mothers with anti-Ro and/or anti-La antibodies. Am J Perinatol. 2002;19:73–80.
   PubMed Web of Science ®Google Scholar
• Costedoat-Chalumeau N, Amoura Z, Lupoglazoff JM, et al. Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group. Arthritis Rheum. 2004;50:3187–3194.
   PubMed Web of Science ®Google Scholar
• Izmirly PM, Saxena A, Kim MY, et al. Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus. Circulation. 2011;124:1927–1935.
   PubMed Web of Science ®Google Scholar
• Sonesson SE. Diagnosing foetal atrioventricular heart blocks. Scand J Immunol. 2010;72:205–212.
   PubMed Web of Science ®Google Scholar
• Mevorach D, Elchalal U, Rein AJJT. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block. Curr Opin Rheumatol. 2009;21:478–482.
   PubMed Web of Science ®Google Scholar
• Brucato A. Prevention of congenital heart block in children of SSA-positive mothers. Rheumatology (Oxford). 2008;47:i35–37.
   Google Scholar
• Friedman DM, Kim MY, Copel JA, et al. Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study. Circulation. 2008;117:485–493.
   PubMed Web of Science ®Google Scholar
• Levesque K, Morel N, Maltret A, et al. Description of 214 cases of autoimmune congenital heart block: results of the French neonatal lupus syndrome. Autoimmun Rev. 2015;14(12):1154–1160.
   PubMed Web of Science ®Google Scholar
• Friedman DM, Llanos C, Izmirly PM, et al. Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial. Arthritis Rheum. 2010;62(4):1138e46.
   Web of Science ®Google Scholar
• Pisoni CN, Brucato A, Ruffatti A, et al. Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study. Arthritis Rheum. 2010;62(4):1147–1152.
   PubMed Web of Science ®Google Scholar
• Makino S, Yonemoto H, Itoh S, et al. Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and/or Sjögren’s syndrome. Acta Obstet Gynecol Scand. 2007;86(9):1145–1146.
   PubMed Web of Science ®Google Scholar
• Ruffatti A, Favaro M, Brucato A, et al. Apheresis in high risk antiphospholipid syndrome pregnancy and autoimmune congenital heart block. Transfus Apher Sci. 2015;53:269–278.
   PubMed Web of Science ®Google Scholar
• Izmirly PM, Costedoat-Chalumeau N, Pisoni CN, et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation. 2012;126(1):76–82.
   PubMed Web of Science ®Google Scholar
• Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46:1019–1027.
   PubMed Web of Science ®Google Scholar
• Meroni PL, Borghi MO, Raschi E, et al. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol. 2011;7:330–339.
   PubMed Web of Science ®Google Scholar
• de Jesus GR, Agmon-Levin N, Andrade C, et al. 14th international congress on antiphospholipid antibodies task force report on obstetric antiphospholipid syndrome. Autoimmun Rev. 2014;13(8):795–813.
   PubMed Web of Science ®Google Scholar
• Oshiro BT, Silver RM, Scott JR, et al. aPL and fetal death. Obstet Gynecol. 1996;87:489–493.
   PubMed Web of Science ®Google Scholar
• Lateef A, Petri M. Managing lupus patients during pregnancy. Best Pract Res. 2013;27(3):435–447.
   Web of Science ®Google Scholar
• Lateef A, Magder L, Petri M. Decrease in complement (C3) levels during systemic lupus erythematosus pregnancy is associated with higher rates of pre-eclampsia. Arthritis Rheum. 2010;62(10):S193.
   Google Scholar
• Lindheimer MD, Davison JM. Renal biopsy during pregnancy: ‘To b… or not to b…?’. Br J Obstet Gynaecol. 1987;94:932–934.
   PubMedGoogle Scholar
• Chen TK, Gelber AC, Witter FR, et al. Renal biopsy in the management of lupus nephritis during pregnancy. Lupus. 2015;24(2):147–154.
   PubMed Web of Science ®Google Scholar
• Schewitz LJ, Friedman IA, Pollak VE. Bleeding after renal biopsy in pregnancy. Obstet Gynecol. 1965;26:295–304.
   PubMed Web of Science ®Google Scholar
• Ruiz-Irastorza G, Khamashta MA. Lupus and pregnancy: integrating clues from the bench and bedside. Eur J Clin Invest. 2011;41(6):672–678.
   PubMed Web of Science ®Google Scholar
• Pagani G, Reggia R, Andreoli L, et al. The role of second trimester uterine artery Doppler in pregnancies with systemic lupus erythematosus. Prenat Diagnos. 2015;35:447–452.
   PubMed Web of Science ®Google Scholar
• Götestam Skorpen C, Hoeltzenbein M, Tincani A. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75(5):795–810.
   PubMed Web of Science ®Google Scholar
• Verstappen SMM, King Y, Watson KD, et al. Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2011;70(5):823–826.
   PubMed Web of Science ®Google Scholar
• Østensen M, Khamashta M, Lockshin M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther. 2006;8:209–227.
   PubMed Web of Science ®Google Scholar
• Østensen M, Lockshin M, Doria A, et al. Update on safety of biological agents and some immunosuppressive antirheumatic drugs. Rheumatology. 2008;47(3):iii28–31.
   PubMedGoogle Scholar
• Costedoat-Chalumeau N, Amoura Z, Huong DL, et al. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature. Autoimmun Rev. 2005;4:111–115.
   PubMed Web of Science ®Google Scholar
• The Registration Committee of the European Dialysis and Transplant Association. Successful pregnancies in women treated by dialysis and kidney transplantation. Br J Obstet Gynaecol. 1980;87:839–845.
   PubMedGoogle Scholar
• Polifka JE, Friedman JM. Teratogen update: azathioprine and 6- mercaptopurine. Teratology. 2002;65:240–261.
   PubMedGoogle Scholar
• Clearly BJ, Källén B. Early pregnancy azathioprine use and pregnancy outcomes. Birth Defects Res A Clin Mol Teratol. 2009;85:647–654.
   PubMed Web of Science ®Google Scholar
• Hutson JR, Lubetsky A, Walfisch A, et al. The transfer of 6-mercaptopurine in the dually perfused human placenta. Reprod Toxicol. 2011;32(3):349–353.
   PubMed Web of Science ®Google Scholar
• Lee NY, Sai Y, Nakashima E, et al. 6-Mercaptopurine transport by equilibrative nucleoside transporters in conditionally immortalized rat syncytiotrophoblast cell lines TR-TBTs. J Pharm Sci. 2011;100:3773–3782.
   PubMed Web of Science ®Google Scholar
• Sifontis NM, Coscia LA, Constantinescu S, et al. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation. 2006;82:1698–1702.
   PubMed Web of Science ®Google Scholar
• Hahn KME, Johnson PH, Gordon N, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006;107:1219–1226.
   PubMed Web of Science ®Google Scholar
• Powell M, Hill D, Eudy A. Pregnancy outcomes for systemic lupus erythematosus (SLE) subjects with conception during Belimumab intravenous (iv) and subcutaneous (sc) placebo-controlled clinical trials and long term extension trials. Ann Rheum Dis. 2014;73:75–76.
   PubMed Web of Science ®Google Scholar
• Xu Z, Fan J, Luo X, et al. Anticoagulation regimens during pregnancy in patients with mechanical heart valves: a systematic review and meta-analysis. Can J Cardiol. 2015 Nov 12. pii: S0828-282X(15)01581-0.
   Web of Science ®Google Scholar
• Mak A, Cheung MW, Cheak AA, et al. Combination of heparin and aspirin is superior to aspirin alone in enhancing livebirths in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Rheumatology. 2010;49:281–288.
   PubMed Web of Science ®Google Scholar
• Ziakas PD, Pavlou M, Voulgarelis M. Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis. Obstet Gynecol. 2010;115:1256–1262.
   PubMed Web of Science ®Google Scholar
• Erkan D, Patel S, Nuzzo M, et al. Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers. Rheumatology. 2008;47:23–27.
   Web of Science ®Google Scholar
• Del Ross T, Ruffatti A, Visentin MS, et al. Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study. J Rheumatol. 2013;40(4):425–429.
   PubMed Web of Science ®Google Scholar
• Bates SM, Greer IA, Pabinger I, et al. American College of Chest Physicians: Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6_suppl):844S–886S.
   Google Scholar
• Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006;354(23):2443–2451.
   PubMed Web of Science ®Google Scholar
• Ostensen M. Disease specific problems related to drug therapy in pregnancy. Lupus. 2004;13:746e50.
   Web of Science ®Google Scholar
• Clowse ME, Magder L, Petri M. Cyclophosphamide for lupus during pregnancy. Lupus. 2005;14:593–597.
   PubMed Web of Science ®Google Scholar
• Cervera R, Khamashta MA, Hughes GR. The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe. Lupus. 2009;18(10):869–874.
   PubMed Web of Science ®Google Scholar
• Ostensen M. Connective tissue disease: contraception counseling in SLE: an often forgotten duty? Nat Rev Rheumatol. 2011;7(6):315–316.
   PubMed Web of Science ®Google Scholar
• Buyon JP, Kim MY, Guerra MM, et al. Predictors of pregnancy outcomes in patients with lupus: a cohort study. Ann Intern Med. 2015;163(3):153–163.
   PubMed Web of Science ®Google Scholar
• Andreoli L, Fredi M, Nalli C, et al. Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome. J Autoimmun. 2012;38:197–208.
   Web of Science ®Google Scholar